Saif, M.W. 2013. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas. 14, 6 (Nov. 2013), 686–688. DOI:https://doi.org/10.6092/1590-8577/2028.